Trial Profile
Extended malaria prophylaxis in HIV-exposed Ugandan children
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 03 Dec 2015
Price :
$35
*
At a glance
- Drugs Dihydroartemisinin/piperaquine (Primary)
- Indications Malaria
- Focus Adverse reactions; Therapeutic Use
- 03 Dec 2015 New trial record